About LabGenius
LabGenius is a Technology company based in London (United Kingdom) founded in 2012 by Leila Rastegar Zegna and James Field. AI-driven platform for discovering and optimizing therapeutic antibodies for treatments. It operates on a B2B model in Technology and Healthcare sectors. The company has 54 employees. Its chief executive, as recorded, is James Field. LabGenius offers products and services including EVAâ„¢ Platform. Its focus areas include Life Sciences, AI Applications, Drug Discovery and Therapeutic Development. Its legal entity is LABGENIUS LIMITED. Its competitors include Antiverse and Orbit Discovery; 2 of its 2 listed competitors have raised funding.
Company details
LabGenius Therapeutics develops therapeutic antibodies using AI and machine intelligence through the EVA platform, which automates discovery and co-optimization of complex molecules. The company focuses on selectivity-enhanced antibodies for solid tumours, combining human expertise with technology. Based in London, UK, it advances internal pipelines and potential partnerships in biotechnology.
- Headquarters London, United Kingdom
- Employees 54
- Founders Leila Rastegar Zegna, James Field
- SectorsTechnologyHealthcare
- Website labgeni.us
- Social LinkedIn X Facebook
- Legal Name Labgenius Limited
- Date of Incorporation 17 Aug, 2012
- Jurisdiction LONDON, UNITED KINGDOM
- Employee Count54
Products & Services of LabGenius
LabGenius offers a comprehensive portfolio of products and services, including EVA™ Platform.
Automated system for rapid identification of therapeutic antibodies.
People of LabGenius
42 people are tracked at LabGenius (12 in leadership, 7 in board & advisors, 23 in team); the tracked headcount is 54.
| Name | Role | Group |
|---|---|---|
Leila Rastegar Zegna | Co-Founder | Leadership |
James Field | CEO, Founder | Leadership |
Michael Mullin | Head, Antibody Engineering | Leadership |
Edward de Moraville | VP Of Finance | Leadership |
Lucy Shaw | Head Of Communications | Leadership |
Gino Van Heeke | Chief Scientific Officer | Leadership |
Caroline Thomson | VP, People | Leadership |
Didier Landais | COO | Leadership |
Becky Mirnateghi | Senior People Partner | Leadership |
Winston Haynes | Head of Data Science & Machine Learning | Leadership |
Leo Wossnig | Chief Technology Officer | Leadership |
Louise Clark | Executive Assistant To CEO | Leadership |
Irina Haivas | Non-Executive Director | Board & advisors |
Nan Li | Non-Executive Director | Board & advisors |
Zavain Dar | Non-Executive Director | Board & advisors |
Aaron Kimball | Advisor | Board & advisors |
Patrick Pichette | Advisor | Board & advisors |
Edwin Moses | Chairman Of The Board | Board & advisors |
Chris Gibson | Advisor | Board & advisors |
Dan Foxler | Principal Scientist, Cell Biology & Assay Development | Team |
22 more people are available in the full profile.
Complete people profiles for LabGenius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of LabGenius
LabGenius has 2 listed competitors in our database, 2 of them funded. They include Antiverse and Orbit Discovery.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| antiverse.io | 2017 | Cardiff, United Kingdom | $9.58M | 7 | An AI platform for antibody drug discovery is provided. | |
| orbitdiscovery.com | 2015 | Oxford, United Kingdom | $15.73M | 26 | Drug discovery platform developed using peptide display engine. |
Detailed competitors of LabGenius
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Labgenius
Complete news archive for LabGenius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabGenius
LabGenius was founded in 2012.
LabGenius is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
James Field is the CEO of LabGenius, as recorded in our data. They have also founded this company.
LabGenius has 54 employees.
LabGenius Therapeutics develops therapeutic antibodies using AI and machine intelligence through the EVA platform, which automates discovery and co-optimization of complex molecules. The company focuses on selectivity-enhanced antibodies for solid tumours, combining human expertise with technology. Based in London, UK, it advances internal pipelines and potential partnerships in biotechnology.
LabGenius's top competitors include Antiverse and Orbit Discovery.
LabGenius offers EVAâ„¢ Platform.
LabGenius operates through Labgenius Limited.